GILGAMESH PHARMACEUTICALS
LIVE

Serial Number

97526318

Owner

GILGAMESH PHARMACEUTICALS, INC.

Attorney

Keith A. Weltsch

Filing Date

Jul 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GILGAMESH PHARMACEUTICALS Trademark

Serial Number: 97526318

GILGAMESH PHARMACEUTICALS is a trademark filed by GILGAMESH PHARMACEUTICALS, INC. on July 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

GILGAMESH PHARMACEUTICALS, INC. (3 trademarks)

c/o Jonathan Sporn
New York, NY 10003

Entity Type: 03

Trademark Details

Filing Date

July 29, 2022

Registration Date

Not Registered

Published for Opposition

September 26, 2023

Goods & Services

Pharmaceuticals, namely, pharmaceutical and drug preparations and substances for use in treating cancer and for use in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, and longevity; Diagnostic biomarker reagents for pharmaceutical and medical purposes; predictive biomarker reagents for medical use, namely, for pharmaceuticals and drugs for use in treating cancer and in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, and longevity

Filing History

SOU EXTENSION RECEIVED WITH TEAS PETITION
Jul 2, 2026 TPEX
NOTICE OF REVIVAL - E-MAILED
Jul 2, 2026 NREV
PETITION TO REVIVE-GRANTED
Jul 2, 2026 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 2, 2026 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 22, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 22, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 22, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 21, 2025 EX4G
SOU EXTENSION 4 FILED
Nov 21, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 21, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 16, 2025 EX3G
SOU EXTENSION 3 FILED
May 16, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 22, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 21, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 21, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 18, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 17, 2024 EX1G
SOU EXTENSION 1 FILED
May 17, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 17, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 18, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 18, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 18, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 18, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 25, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 25, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 25, 2023 CNRT
ASSIGNED TO EXAMINER
May 16, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2022 NWOS
NEW APPLICATION ENTERED
Aug 2, 2022 NWAP